Intra-arterial Gemcitabine vs. IV Gemcitabine and Nab-Paclitaxel Following Radiotherapy for LAPC

Clinical trial NCT03257033 · RECRUITING

Trial details

NCT number: NCT03257033
Sponsor: RenovoRx
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Locally Advanced Pancreatic Cancer

Start date: 2018-03-12
Primary completion: 2026-06-01
Enrollment: 190

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.